Crisis in science is turning Nobel laureates into fighters for scientific revolution
This week, an article appeared in The Atlantic magazine [titled 'The Nobel Prize winner who thinks we have the universe all wrong']. It featured Adam Riess, who won a Nobel Prize for the shocking discovery that the expansion of universe is accelerating, due to Dark Energy. But now he thinks that the theory must be wrong. The article warned about scientists talking of revolution. A growing number now say that the 'standard model of cosmology' should be replaced. Adam Riess is among them. Way back in 2013, in a conversation with WIRED, David Gross, a Nobel laureate in physics, warned about the crisis in physics and advocated a revolution. ['Nobel laureate says physics is in need of a revolution'; WIRED; Peter Byrne].
An article in NewScientist (Dan Hooper) was titled 'The four puzzles that tell us a cosmological revolution is coming'. Another article in Live Science (Kelly Dickerson) was titled 'Why a Physics Revolution Might Be on Its Way: Physics may be turned on its head soon'. Global newspapers (BBC News, The New York Times, The Guardian, Forbes, et al) are raising alarm over the crisis in both physics and cosmology. Actually, science is in crisis, because nature does not draw clear lines between biology, chemistry, physics, math, and cosmology. Such demarcations are human-made, and artificial. After all, biology is based on chemistry, which in turn is based on physics. Global news media as well as prominent scientists are predicting that a BIG scientific revolution is imminent.
A scientific revolution is INEVITABLE because of four strong reasons:
1) All three conditions are satisfied. The three key steps to overthrow and replace any accepted scientific theory are: a) Reproduce the successes of the presently accepted theory. b) Explain what it cannot. c) Make new predictions that differ and can be tested.
2) Physics and cosmology are both in crisis due to wrong notion about the shape, size and workings of the universe. The universe is actually like a (hyper) balloon, and is expanding.
3) Science rests on faulty Math. Luckily, the mistakes are so easy to comprehend that even the common people can easily understand what is wrong. A baker can understand, and so can butchers or cobblers.
4) Einstein was wrong. His concept of four dimensional SpaceTime continuum is the biggest mistake in science. Time itself is NOT the fourth dimension; time emerges from motion along 4th space dimension.
Every scientific revolution in the past has ended up having enormous social and cultural influence. For example, Copernicus's helio-centrism threatened human sense of being right in the center of the universe (and hence the 'sun centric model' was bitterly opposed by the powerful church but ultimately all oppositions proved futile. In fact, the church had to issue a public apology recently for its role). Darwin's theory of evolution challenged the intuition that humans were fundamentally different from other animals. People during that time were outraged and dismissed it as plain nonsense. Yet, yesterday's nonsense ended up as today's commonsense! Einstein's relativity upended all faith in common sense ideas about the flow of time. Time started mixing with space for very fast moving objects, and time revealed its character as another dimension!
The upcoming scientific revolution shall be the greatest ever, and force humans to change the way of thinking about the most basic features of the universe, including the nature of space and time. Space and Time underlies Physics and Cosmology, and are the most fundamental concepts imaginable in entire Science. It will be a conceptual revolution that would have implications far beyond the world of science. The scale of social and cultural impact of the upcoming scientific revolution is quite unthinkable.
A scientific revolution is unstoppable. No one can stop a revolution whose time has come.
[194 National Anthems tunes have been merged into a single tune using World's most intelligent, musical A.I. software 'Emmy', to create this United Nations Anthem (World Anthem). Kindly watch and share: https://www.youtube.com/watch?v=0SHycxT5-oM ]
Mr. Joseph T. Kurien (a former Cochin University graduate) is an independent researcher and a part-time science writer. He presently works in Manappuram software and consultancy.
Media Contact
Company Name: Manappuram software and consultancy
Contact Person: Joseph T. Kurien
Email: Send Email
State: Kerala
Country: India
Website: https://www.facebook.com/profile.php?id=61559986357449
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
a day ago
- Globe and Mail
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen ('Tevogen Bio Holdings Inc.' or 'Company') (Nasdaq: TVGN), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a biotechnology innovator into a dynamic enterprise expanding into artificial intelligence through Our mission remains steadfast: delivering clinically impactful, economically accessible therapies by leveraging cutting-edge science and technology. Tevogen has become a recognized name for its business philosophy of social responsibility, patient affordability and cost efficiency. In under five years, we validated our proprietary ExacTcell™ platform, completed successful proof-of-concept clinical trial of the platforms first product, established drug discovery R&D center — currently in the process of establishing our own GMP cell manufacturing facility, expanded corporate infrastructure, built a robust intellectual property portfolio, and established one of the pioneering AI initiatives in the industry — assets of significant value, while maintaining 74% insider equity ownership. With the successful launch of our proprietary AI-driven PredicTcell™ platform, we've significantly enhanced target discovery efficiency. Strategic partnerships with global technology leaders, such as Microsoft and Databricks, have accelerated our progress. Recent patent filings further secure our intellectual property in AI-driven predictive modeling, positioning us at the forefront of innovation. Importantly, Tevogen Bio is well capitalized, having access to necessary funding we may require to fully execute our current growth strategy, including the accelerated development of While the sector faces significant challenges, our company continues to grow, underscoring the foundational strength of our company. We deeply appreciate your continued support as we work toward our vision of transforming healthcare through democratizing access. It feels good to be part of this growth story and am grateful to my colleagues at Tevogen for their exceptional expertise, dedication, and, above all, their compassion for others. Sincerely, Ryan Saadi, MD, MPH Founder and CEO, Tevogen Bio Recent Announcements Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility Builds Alpha Version of PredicTcell Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs Tevogen's New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation Forward-Looking Statements This press release contains certain forward-looking statements, including without limitation statements relating to: Tevogen's plans for its research and manufacturing capabilities; expectations regarding future growth; expectations regarding the healthcare and biopharmaceutical industries; and Tevogen's development of, the potential benefits of, and patient access to its product candidates for the treatment of infectious diseases and cancer. Forward-looking statements can sometimes be identified by words such as 'may,' 'could,' 'would,' 'expect,' 'anticipate,' 'possible,' 'potential,' 'goal,' 'opportunity,' 'project,' 'believe,' 'future,' and similar words and expressions or their opposites. These statements are based on management's expectations, assumptions, estimates, projections and beliefs as of the date of this press release and are subject to a number of factors that involve known and unknown risks, delays, uncertainties and other factors not under the company's control that may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements. Factors that could cause actual results, performance, or achievements to differ from those expressed or implied by forward-looking statements include, but are not limited to: that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; changes in the markets in which Tevogen competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen may not be able to execute its growth strategies or may experience difficulties in managing its growth and expanding operations; the risk that Tevogen may not be able to develop and maintain effective internal controls; the failure to achieve Tevogen's commercialization and development plans and identify and realize additional opportunities, which may be affected by, among other things, competition, the ability of Tevogen to grow and manage growth economically and hire and retain key employees; the risk that Tevogen may fail to keep pace with rapid technological developments to provide new and innovative products and services or make substantial investments in unsuccessful new products and services; risks related to the ability to develop, license or acquire new therapeutics; the risk of regulatory lawsuits or proceedings relating to Tevogen's business; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review, approval and commercial development; risks associated with intellectual property protection; Tevogen's limited operating history; and those factors discussed or incorporated by reference in Tevogen's Annual Report on Form 10-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law. Contacts
Globe and Mail
a day ago
- Globe and Mail
Frequency Electronics Announces 2025 Quantum Sensing Summit in New York City
MITCHEL FIELD, N.Y., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. ('FEI' or the 'Company') (NASDAQ-FEIM), a leading provider of precision timing and frequency control products, today announced it will host the 2025 Quantum Sensing Summit on October 29–30, 2025, in New York City. The event will bring together leaders from government, industry, and research to accelerate the transition of quantum sensing technologies from the lab to mission-ready deployment. Building on the success of the inaugural 2024 summit, this year's two-day program will feature keynotes, panels, and technical sessions highlighting enabling technologies such as Rydberg and NV-diamond sensors, photonic integrated circuits (PICs), frequency combs, and ultra-low-noise oscillators. ' Quantum sensing is at the heart of the next technological revolution, ' said Dr. Tom McClelland, CEO of Frequency Electronics. 'This summit is designed to forge the partnerships and strategies that turn today's breakthroughs into tomorrow's deployable solutions.' The summit is expected to attract 100–150 participants, including key government decision-makers, program managers, and industry innovators, providing a unique forum for collaboration and policy influence in the emerging quantum technology landscape. About Frequency Electronics Frequency Electronics, Inc. (FEI) is a world leader in the design, development and manufacture of high precision timing, frequency generation and RF control products for space and terrestrial applications. FEI's products are used in satellite payloads and in other commercial, government and military systems including C4ISR and electronic warfare, missiles, UAVs, aircraft, GPS, secure communications, energy exploration and wireline and wireless networks. FEI-Zyfer provides GPS and secure timing capabilities for critical military and commercial applications; FEI-Elcom Tech provides Electronic Warfare ('EW') sub-systems and state-of-the-art RF and microwave products. FEI has received over 100 awards of excellence for achievements in providing high performance electronic assemblies for over 150 space and DOD programs. The Company invests significant resources in research and development to expand its capabilities and markets. FEI's Mission Statement: 'Our mission is to transform discoveries and demonstrations made in research laboratories into practical, real-world products. We are proud of a legacy which has delivered precision time and frequency generation products, for space and other world-changing applications that are unavailable from any other source. We aim to continue that legacy while adapting our products and expertise to the needs of the future. With a relentless emphasis on excellence in everything we do, we aim, in these ways, to create value for our customers, employees, and stockholders.' Forward-Looking Statements The statements in this press release regarding future earnings and operations and other statements relating to the future constitute 'forward-looking' statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, our inability to integrate operations and personnel, actions by significant customers or competitors, general domestic and international economic conditions, reliance on key customers, continued acceptance of the Company's products in the marketplace, competitive factors, new products and technological changes, product prices and raw material costs, dependence upon third-party vendors, other supply chain related issues, increasing costs for materials, operating related expenses, competitive developments, changes in manufacturing and transportation costs, the availability of capital, the outcome of any litigation and arbitration proceedings, and failure to maintain an effective system of internal controls over financial reporting. The factors listed above are not exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in our filings with the Securities and Exchange Commission. The Company's Annual Report on Form 10-K for the fiscal year ended April 30, 2024, filed on August 2, 2024 with the Securities and Exchange Commission includes additional factors that could materially and adversely impact the Company's business, financial condition and results of operations, as such factors are updated from time to time in our periodic filings with the Securities and Exchange Commission, which are accessible on the Securities and Exchange Commission's website at Moreover, the Company operates in a very competitive and rapidly changing environment. New factors emerge from time to time and it is not possible for management to predict the impact of all these factors on the Company's business, financial condition or results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, investors should not rely on forward-looking statements as a prediction of actual results. Any or all of the forward-looking statements contained in this press release and any other public statement made by the Company or its management may turn out to be incorrect. The Company expressly disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
CTV News
a day ago
- CTV News
Astronauts launch to the space station after sidelined by Boeing's troubled Starliner
Astronauts, from left, Oleg Platonov, of Russia, Mike Fincke, Zena Cardman, and Kimiya Yui, of Japan, pose for a photo as they leave the Operations and Checkout Building for a trip the Kennedy Space Center's Launch Pad 39-A and a planned liftoff on a SpaceX Falcon 9 rocket Friday, Aug. 1, 2025, in Cape Canaveral , Fla. (AP Photo/John Raoux) CAPE CANAVERAL, Fla. — Astronauts sidelined for the past year by Boeing's Starliner trouble blasted off to the International Space Station on Friday, getting a lift from SpaceX. The U.S.-Japanese-Russian crew of four rocketed from NASA's Kennedy Space Center. They'll replace colleagues who launched to the space station in March as fill-ins for NASA's two stuck astronauts. Their SpaceX capsule should reach the orbiting lab this weekend and stay for at least six months. Zena Cardman, a biologist and polar explorer who should have launched last year, was yanked along with another NASA crewmate to make room for Starliner's star-crossed test pilots. The botched Starliner demo forced Butch Wilmore and Suni Williams to switch to SpaceX to get back from the space station more than nine months after departing on what should have been a weeklong trip. Ensuring their safe return 'meant stepping aside,' Cardman said before her launch. 'Every astronaut wants to be in space. None of us want to stay on the ground, but it's not about me,' said Cardman, the flight commander. Even after launch, 'things can change at the last minute, so I'll count myself very fortunate when the hatch opens' to the space station. NASA's Mike Fincke — Cardman's co-pilot — was the backup for Wilmore and Williams on Starliner, making those three still the only ones certified to fly it. Fincke and Japan's Kimiya Yui, former military officers with previous spaceflight experience, were training for Starliner's second astronaut mission. With Starliner grounded until 2026, NASA switched the two to the latest SpaceX flight. Rounding out the crew is Russia's Oleg Platonov. The former fighter pilot was pulled a few years ago from the Russian Soyuz flight lineup because of an undisclosed health issue that he said has since been resolved. On hand for the first launch attempt on Thursday, NASA's new acting administrator, Transportation Secretary Sean Duffy, met with Roscosmos director general Dmitry Bakanov, an invited guest. The two discussed future collaboration, then left town after thick clouds forced a last-minute delay. 'What we learn on these missions is what's going to get us to the moon and then from the moon to Mars, which is I think the direction that NASA has to be,' Duffy said in a NASA interview. 'There's critical real estate on the moon. We want to claim that real estate for ourselves and our partners.' To save money in light of tight budgets, NASA is looking to increase its space station stays from six months to eight months, a move already adopted by Russia's space agency. SpaceX is close to certifying its Dragon capsules for longer flights, which means the newly launched crew could be up there until April. NASA is also considering smaller crews — three astronauts launching on SpaceX instead of the typical four — to cut costs. As for Starliner, NASA is leaning toward launching the next one with cargo before flying another crew. Engineers are still investigating the thruster failures and helium leaks that bedeviled Starliner following liftoff. Time is running out as NASA looks to abandon the aging space station by 2030. An air leak on the Russian side of the station remains unresolved after years of patching. 'I am not in the least worried' about the leak, which is localized, Platonov said earlier this month. Marcia Dunn, The Associated Press
